P-glycoprotein (ABCB1/MDR1) limits brain accumulation and Cytochrome P450-3A (CYP3A) restricts oral availability of the novel FGFR4 inhibitor fisogatinib (BLU-554)
2020 ◽
Vol 573
◽
pp. 118842
◽
2018 ◽
Vol 143
(8)
◽
pp. 2029-2038
◽
2002 ◽
Vol 301
(2)
◽
pp. 586-593
◽
2018 ◽
Vol 15
(11)
◽
pp. 5124-5134
◽
2012 ◽
Vol 132
(10)
◽
pp. 2439-2447
◽
Keyword(s):
2011 ◽
Vol 35
(2)
◽
pp. 202-205
◽
2005 ◽
Vol 28
(5)
◽
pp. 461-466
◽
Keyword(s):
2014 ◽
Vol 77
(6)
◽
pp. 1039-1050
◽
2006 ◽
Vol 79
(3)
◽
pp. 218-230
◽
Keyword(s):